Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Paul Bunn

Concepts (1204)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
331
2023
2207
20.620
Why?
Carcinoma, Non-Small-Cell Lung
166
2023
964
16.530
Why?
ErbB Receptors
67
2023
557
6.790
Why?
Antineoplastic Agents
100
2023
1891
6.260
Why?
Antineoplastic Combined Chemotherapy Protocols
91
2023
1359
5.970
Why?
Carcinoma, Small Cell
103
2008
159
5.280
Why?
Quinazolines
37
2016
241
4.710
Why?
Small Cell Lung Carcinoma
13
2023
77
4.670
Why?
Protein Kinase Inhibitors
32
2023
788
3.480
Why?
Paclitaxel
28
2011
192
2.660
Why?
Carboplatin
24
2019
139
2.420
Why?
Guanine
11
2007
76
2.220
Why?
Glutamates
11
2007
59
2.030
Why?
Molecular Targeted Therapy
13
2019
348
2.030
Why?
Neoplasm Staging
63
2018
1177
1.960
Why?
Adenocarcinoma
30
2017
797
1.890
Why?
Humans
510
2023
115888
1.720
Why?
Antibodies, Monoclonal
42
2018
1262
1.660
Why?
Biomarkers, Tumor
35
2021
1045
1.600
Why?
Neoadjuvant Therapy
9
2023
301
1.590
Why?
Deoxycytidine
11
2004
140
1.580
Why?
Taxoids
13
2013
94
1.510
Why?
Antimetabolites, Antineoplastic
9
2007
83
1.460
Why?
Skin Neoplasms
55
2010
760
1.450
Why?
Mutation
29
2023
3369
1.400
Why?
Gene Expression Regulation, Neoplastic
22
2018
1143
1.370
Why?
Clinical Trials as Topic
48
2019
945
1.360
Why?
Receptor, ErbB-2
11
2019
302
1.350
Why?
Lymphoma
47
1991
177
1.340
Why?
Combined Modality Therapy
52
2023
1128
1.330
Why?
Antineoplastic Agents, Phytogenic
10
2007
181
1.300
Why?
Etoposide
25
2023
149
1.260
Why?
Survival Analysis
33
2019
1221
1.170
Why?
Carcinoma, Squamous Cell
21
2023
577
1.170
Why?
Sezary Syndrome
36
1996
43
1.140
Why?
Cisplatin
28
2018
263
1.120
Why?
Drug Resistance, Neoplasm
19
2023
638
1.100
Why?
Protein-Tyrosine Kinases
9
2023
394
1.100
Why?
Lymphoma, T-Cell, Cutaneous
9
2010
40
1.090
Why?
Mycosis Fungoides
38
1996
61
1.060
Why?
Erlotinib Hydrochloride
12
2015
65
1.030
Why?
Aged
135
2023
19295
1.020
Why?
Antibodies, Monoclonal, Humanized
11
2023
664
1.000
Why?
Bradykinin
9
2005
46
0.990
Why?
In Situ Hybridization, Fluorescence
21
2018
310
0.990
Why?
Vinblastine
7
2003
61
0.980
Why?
Immunotherapy
13
2020
480
0.960
Why?
Precision Medicine
4
2018
356
0.960
Why?
Middle Aged
164
2023
27079
0.950
Why?
Proto-Oncogene Proteins
15
2023
609
0.910
Why?
Folic Acid Antagonists
4
2005
8
0.900
Why?
Prognosis
52
2019
3342
0.900
Why?
Angiogenesis Inhibitors
8
2018
216
0.880
Why?
Tumor Cells, Cultured
29
2014
850
0.860
Why?
Male
200
2023
56121
0.840
Why?
Gene Dosage
10
2018
127
0.840
Why?
Female
192
2023
60075
0.810
Why?
Survival Rate
23
2020
1653
0.800
Why?
Neutropenia
11
2022
127
0.790
Why?
Liposomes
2
2022
149
0.780
Why?
Immunohistochemistry
24
2020
1643
0.770
Why?
Gene Amplification
9
2019
96
0.760
Why?
Pemetrexed
13
2016
27
0.750
Why?
Receptor Protein-Tyrosine Kinases
10
2022
225
0.740
Why?
Chemotherapy, Adjuvant
10
2015
334
0.720
Why?
Enzyme Inhibitors
9
2016
758
0.720
Why?
Brain Neoplasms
18
2023
979
0.710
Why?
Smoking
19
2019
1468
0.700
Why?
Retirement
1
2020
27
0.680
Why?
Treatment Outcome
41
2023
9165
0.670
Why?
Pathologists
1
2019
15
0.660
Why?
Antigens, Neoplasm
13
2009
224
0.630
Why?
Tubulin Modulators
1
2018
9
0.620
Why?
T-Lymphocytes
54
2020
1754
0.610
Why?
Furans
1
2018
22
0.610
Why?
Ketones
1
2018
44
0.600
Why?
Randomized Controlled Trials as Topic
20
2018
1215
0.600
Why?
Karnofsky Performance Status
1
2016
36
0.570
Why?
Sputum
10
2019
291
0.560
Why?
Aged, 80 and over
33
2019
6437
0.560
Why?
Aurora Kinase B
1
2016
7
0.560
Why?
Thymidylate Synthase
4
2005
11
0.550
Why?
Proto-Oncogene Proteins c-met
6
2020
67
0.550
Why?
Sulindac
5
2007
17
0.550
Why?
Pneumonectomy
3
2015
126
0.540
Why?
Interferon Type I
12
1995
129
0.530
Why?
Awards and Prizes
1
2016
56
0.530
Why?
Medical Oncology
5
2003
230
0.530
Why?
Neoplasm Proteins
5
2009
388
0.530
Why?
Organophosphates
1
2016
90
0.520
Why?
Gene Rearrangement
8
2018
135
0.520
Why?
Adult
119
2023
30813
0.520
Why?
Cell Line, Tumor
18
2019
2749
0.510
Why?
Dose-Response Relationship, Drug
21
2016
1868
0.490
Why?
Genomics
3
2020
640
0.480
Why?
Neoplasms
10
2010
2111
0.470
Why?
Chemoprevention
5
2019
88
0.470
Why?
Cell Cycle
11
2015
546
0.470
Why?
Esophagitis
3
2012
65
0.450
Why?
Cadherins
6
2012
175
0.450
Why?
Genes, erbB-1
6
2015
18
0.440
Why?
Precancerous Conditions
6
2018
156
0.440
Why?
Disease Progression
14
2022
2424
0.430
Why?
AMP-Activated Protein Kinases
1
2014
175
0.420
Why?
Mice, Nude
18
2017
639
0.410
Why?
Melanoma
5
2022
649
0.400
Why?
Genes, erbB-2
7
2017
26
0.400
Why?
Disease-Free Survival
11
2018
621
0.400
Why?
Cell Transformation, Neoplastic
5
2004
312
0.390
Why?
Neuropeptides
6
1998
65
0.390
Why?
Pyridines
6
2013
425
0.390
Why?
Proto-Oncogene Proteins p21(ras)
9
2019
228
0.390
Why?
Drug Administration Schedule
18
2011
724
0.390
Why?
TOR Serine-Threonine Kinases
1
2014
361
0.380
Why?
Cell Division
22
2007
760
0.380
Why?
Bronchi
7
2018
253
0.380
Why?
Neoplasm Metastasis
15
2019
526
0.370
Why?
National Cancer Institute (U.S.)
1
2010
40
0.370
Why?
Esophagus
1
2012
224
0.370
Why?
Head and Neck Neoplasms
4
2009
425
0.370
Why?
Acrylamides
2
2022
43
0.370
Why?
Global Health
1
2012
292
0.360
Why?
Ribonucleotide Reductases
3
2004
21
0.350
Why?
Time Factors
32
2018
6186
0.350
Why?
Animals
66
2019
32119
0.350
Why?
Early Detection of Cancer
6
2021
340
0.350
Why?
Signal Transduction
17
2017
4525
0.340
Why?
Drug Screening Assays, Antitumor
9
2009
180
0.340
Why?
Cell Proliferation
9
2018
2196
0.340
Why?
Fever
5
2001
280
0.340
Why?
Genotype
2
2014
1843
0.340
Why?
Predictive Value of Tests
12
2014
1817
0.340
Why?
Drug Delivery Systems
2
2010
301
0.340
Why?
Phosphorylation
6
2016
1560
0.330
Why?
Drug Monitoring
1
2010
184
0.330
Why?
B7-H1 Antigen
2
2022
138
0.330
Why?
Calcium
6
2002
1102
0.330
Why?
Receptors, Vascular Endothelial Growth Factor
3
2009
104
0.320
Why?
Salvage Therapy
2
2007
128
0.320
Why?
Xenograft Model Antitumor Assays
8
2019
703
0.320
Why?
Pyrazoles
5
2013
362
0.320
Why?
Drug Therapy, Combination
27
2002
961
0.310
Why?
Biomarkers
4
2023
3473
0.310
Why?
Lymphoma, Non-Hodgkin
6
2001
72
0.310
Why?
Flow Cytometry
14
2006
1058
0.300
Why?
Mass Screening
5
2020
1023
0.300
Why?
Cancer Vaccines
1
2009
137
0.300
Why?
Meta-Analysis as Topic
6
2017
163
0.300
Why?
Mesothelioma
3
2004
31
0.290
Why?
Neoplasms, Experimental
4
2002
153
0.290
Why?
Radiation-Sensitizing Agents
2
1997
38
0.290
Why?
Leukemia
16
2018
207
0.290
Why?
Receptors, KIR
2
2018
89
0.280
Why?
Camptothecin
5
2017
97
0.280
Why?
ras Proteins
7
2014
137
0.280
Why?
Mice
32
2019
15072
0.280
Why?
Protease Inhibitors
2
2004
102
0.280
Why?
Oligopeptides
4
2005
248
0.280
Why?
Interferons
7
1995
152
0.280
Why?
Phosphatidylinositol 3-Kinases
4
2023
332
0.270
Why?
Oncogene Proteins, Fusion
3
2018
178
0.270
Why?
Lung
14
2023
3684
0.270
Why?
Bradykinin Receptor Antagonists
2
2002
4
0.260
Why?
Proto-Oncogene Proteins B-raf
5
2015
190
0.260
Why?
Carcinoma in Situ
4
2019
44
0.260
Why?
Recombinant Proteins
14
1998
1243
0.260
Why?
Neoplasm Recurrence, Local
9
2017
862
0.260
Why?
Thrombocytopenia
7
2000
175
0.250
Why?
Apoptosis
9
2018
2377
0.250
Why?
Biomedical Research
3
2010
590
0.250
Why?
Cyclooxygenase Inhibitors
2
2002
72
0.250
Why?
Genes, ras
5
2015
91
0.250
Why?
Antigens, Surface
10
1988
151
0.250
Why?
Gene Expression Profiling
8
2016
1547
0.240
Why?
Tankyrases
2
2016
12
0.240
Why?
Liver Neoplasms
7
2015
521
0.240
Why?
Indium Radioisotopes
5
1991
24
0.240
Why?
Radiotherapy Dosage
13
2007
246
0.240
Why?
Neovascularization, Pathologic
7
2015
283
0.240
Why?
Boronic Acids
1
2004
33
0.240
Why?
Tumor Microenvironment
3
2023
424
0.240
Why?
Committee Membership
1
2003
2
0.230
Why?
Leukemia, Lymphoid
7
1987
27
0.230
Why?
Volatile Organic Compounds
3
2013
54
0.230
Why?
Pyrazines
1
2004
70
0.230
Why?
Organophosphorus Compounds
1
2004
73
0.230
Why?
Transplantation, Heterologous
9
2006
188
0.230
Why?
Organizational Objectives
1
2003
71
0.230
Why?
United States
21
2020
12339
0.220
Why?
Follow-Up Studies
18
2019
4446
0.220
Why?
Anticarcinogenic Agents
1
2004
67
0.220
Why?
Anti-Bacterial Agents
23
2001
1486
0.220
Why?
Delivery of Health Care
1
2010
847
0.220
Why?
Oncogene Addiction
1
2023
5
0.220
Why?
HTLV-I Infections
2
1996
21
0.220
Why?
Neoplasm Transplantation
11
2004
235
0.220
Why?
Retrospective Studies
17
2019
12615
0.210
Why?
Receptor, ErbB-3
3
2009
42
0.210
Why?
Penicillins
22
1969
52
0.210
Why?
Cluster Analysis
4
2016
466
0.210
Why?
Iodine Radioisotopes
5
1992
125
0.210
Why?
Doxorubicin
21
2002
290
0.210
Why?
Organoplatinum Compounds
3
2006
40
0.210
Why?
Growth Substances
4
2000
136
0.210
Why?
Artificial Intelligence
1
2023
146
0.210
Why?
Alkyl and Aryl Transferases
1
2002
34
0.210
Why?
Biopsy
12
2023
1056
0.200
Why?
Airway Obstruction
2
2003
170
0.200
Why?
Carcinoma, Bronchogenic
10
1984
17
0.200
Why?
Aniline Compounds
1
2022
73
0.200
Why?
Carcinoma, Transitional Cell
1
2022
54
0.200
Why?
Roxithromycin
1
2001
1
0.200
Why?
Iloprost
2
2012
46
0.200
Why?
Quality of Life
5
2022
2391
0.200
Why?
Research Design
7
2008
947
0.200
Why?
DNA, Neoplasm
8
2013
156
0.200
Why?
Biological Products
2
2023
172
0.200
Why?
Prospective Studies
15
2023
6266
0.190
Why?
Neprilysin
2
1998
47
0.190
Why?
Topoisomerase I Inhibitors
2
2017
16
0.190
Why?
Cell Cycle Checkpoints
2
2018
84
0.190
Why?
Biomarkers, Pharmacological
2
2019
26
0.190
Why?
Diarrhea
1
2022
173
0.190
Why?
Cell Line
24
2000
2655
0.190
Why?
Pleural Neoplasms
2
2016
18
0.190
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2
2014
138
0.190
Why?
Antibiotic Prophylaxis
1
2001
96
0.180
Why?
Programmed Cell Death 1 Receptor
2
2022
193
0.180
Why?
Societies, Medical
2
2003
690
0.180
Why?
DNA Copy Number Variations
2
2018
157
0.180
Why?
Patient Participation
1
2003
362
0.180
Why?
Ki-67 Antigen
4
2015
104
0.180
Why?
Oncogenes
4
2016
104
0.180
Why?
Adenocarcinoma, Bronchiolo-Alveolar
4
2012
19
0.180
Why?
Urinary Bladder Neoplasms
1
2022
197
0.170
Why?
GTP Phosphohydrolases
3
2015
66
0.170
Why?
Carcinoma, Large Cell
4
2012
14
0.170
Why?
Vaping
1
2020
46
0.170
Why?
Neuroendocrine Tumors
1
2020
83
0.170
Why?
Lymph Nodes
17
1991
422
0.170
Why?
Histone Deacetylase Inhibitors
3
2012
198
0.170
Why?
Epidermal Growth Factor
4
2013
161
0.170
Why?
Kaplan-Meier Estimate
6
2016
819
0.170
Why?
Aminoquinolines
1
2019
20
0.170
Why?
Electronic Nicotine Delivery Systems
1
2020
74
0.170
Why?
Breast Neoplasms
8
2018
1870
0.160
Why?
Bronchoscopy
9
2019
245
0.160
Why?
Practice Guidelines as Topic
3
2019
1403
0.160
Why?
Young Adult
10
2020
10515
0.160
Why?
Friends
1
2019
47
0.160
Why?
Structure-Activity Relationship
6
2018
510
0.160
Why?
Homeodomain Proteins
3
2010
465
0.160
Why?
Radiotherapy, Adjuvant
3
2004
182
0.160
Why?
History, 21st Century
1
2019
164
0.160
Why?
Gene Expression
6
2008
1442
0.160
Why?
Genetic Predisposition to Disease
3
2011
2209
0.160
Why?
Clinical Trials, Phase II as Topic
3
2004
58
0.160
Why?
Wasting Syndrome
1
1998
11
0.160
Why?
Leukemia-Lymphoma, Adult T-Cell
2
1996
13
0.160
Why?
Receptor, IGF Type 1
2
2010
58
0.160
Why?
Caspase 3
2
2018
237
0.160
Why?
Interferon-alpha
4
1995
187
0.150
Why?
Tumor Escape
1
2018
35
0.150
Why?
Forecasting
4
2003
332
0.150
Why?
Proto-Oncogenes
2
2014
26
0.150
Why?
Lung Injury
1
2020
201
0.150
Why?
Smoking Cessation
3
2019
378
0.150
Why?
CpG Islands
1
2018
123
0.150
Why?
Multiple Myeloma
5
1997
93
0.150
Why?
Folic Acid
4
2002
159
0.150
Why?
Cranial Irradiation
2
1995
66
0.150
Why?
Lung Diseases
6
2015
710
0.150
Why?
Palliative Care
6
2003
643
0.150
Why?
Age Factors
6
2016
2915
0.150
Why?
Cyclophosphamide
19
2001
218
0.150
Why?
Genetic Association Studies
2
2017
351
0.150
Why?
Vitamin B 12
3
2002
115
0.150
Why?
Clinical Protocols
1
2019
233
0.150
Why?
Mutagenesis, Insertional
1
2017
60
0.150
Why?
Bone Marrow
10
1992
248
0.150
Why?
Proportional Hazards Models
6
2016
1088
0.150
Why?
HLA Antigens
4
1988
222
0.140
Why?
Tumor Suppressor Protein p53
2
2017
448
0.140
Why?
Receptors, KIR2DL3
1
2016
8
0.140
Why?
Receptors, KIR2DL4
1
2016
3
0.140
Why?
Receptors, KIR2DL1
1
2016
17
0.140
Why?
Receptors, KIR3DL1
1
2016
15
0.140
Why?
Interleukin-2
3
1995
414
0.140
Why?
Patients
1
2018
164
0.140
Why?
Polyploidy
1
2016
16
0.140
Why?
Empathy
2
2009
141
0.140
Why?
DNA Mutational Analysis
6
2017
378
0.140
Why?
Computational Biology
2
2018
528
0.140
Why?
Chemoradiotherapy
1
2018
187
0.140
Why?
RNA, Messenger
7
2014
2581
0.140
Why?
Genes, myc
1
2016
47
0.140
Why?
Bone Neoplasms
4
2015
195
0.140
Why?
Genetic Therapy
4
2015
267
0.140
Why?
Pleural Effusion, Malignant
1
2016
14
0.140
Why?
Translocation, Genetic
1
2016
94
0.140
Why?
Drug Evaluation
14
1992
79
0.140
Why?
Lymphocytes, Tumor-Infiltrating
1
2016
107
0.130
Why?
Disease Models, Animal
5
2016
3583
0.130
Why?
Lymphoma, AIDS-Related
1
1996
13
0.130
Why?
Human T-lymphotropic virus 1
1
1996
23
0.130
Why?
Clinical Trials, Phase III as Topic
3
2016
84
0.130
Why?
Cohort Studies
9
2019
4961
0.130
Why?
Dimerization
3
2002
177
0.130
Why?
Peritoneal Neoplasms
1
2016
54
0.130
Why?
Membrane Proteins
3
2015
1033
0.130
Why?
Molecular Biology
1
2016
56
0.130
Why?
Radiosurgery
2
2014
298
0.130
Why?
Sex Factors
6
2015
1743
0.130
Why?
Tumor Burden
1
2016
261
0.130
Why?
Nerve Tissue Proteins
1
1999
538
0.130
Why?
Antibodies, Viral
11
2022
520
0.130
Why?
DNA Methylation
2
2018
498
0.130
Why?
Remission Induction
7
2019
240
0.130
Why?
Ifosfamide
4
2008
32
0.130
Why?
Prevalence
4
2023
2271
0.120
Why?
Granulocyte Colony-Stimulating Factor
3
2001
70
0.120
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1995
139
0.120
Why?
Patient-Specific Modeling
1
2014
37
0.120
Why?
Bronchopulmonary Dysplasia
1
2019
330
0.120
Why?
Biosensing Techniques
2
2013
102
0.120
Why?
Up-Regulation
3
2002
824
0.120
Why?
HIV
1
1996
209
0.120
Why?
Amino Acid Sequence
6
1999
2000
0.120
Why?
Administration, Oral
5
2012
731
0.120
Why?
Transcription Factors
3
2010
1530
0.120
Why?
Adrenal Gland Neoplasms
1
2015
81
0.120
Why?
Lymph Node Excision
1
2015
140
0.120
Why?
Genetic Testing
2
2011
385
0.120
Why?
Correction of Hearing Impairment
1
2014
12
0.120
Why?
Drug Synergism
4
2016
316
0.120
Why?
Tomography, Spiral Computed
1
2013
24
0.120
Why?
Attitude to Computers
1
2014
27
0.120
Why?
Activities of Daily Living
1
2016
352
0.120
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2014
49
0.120
Why?
Multiplex Polymerase Chain Reaction
1
2014
45
0.110
Why?
Persons With Hearing Impairments
1
2014
21
0.110
Why?
PUVA Therapy
3
1990
5
0.110
Why?
Interferon-gamma
3
1995
731
0.110
Why?
Physicians
2
2019
774
0.110
Why?
Inhibitory Concentration 50
3
2013
78
0.110
Why?
Proto-Oncogene Proteins c-akt
5
2015
399
0.110
Why?
Retroviridae
9
1983
90
0.110
Why?
Sequence Analysis, DNA
2
2014
733
0.110
Why?
Deltaretrovirus Infections
3
1988
6
0.110
Why?
Immunoenzyme Techniques
4
2014
193
0.110
Why?
Software
1
2017
531
0.110
Why?
Wnt Proteins
2
2012
135
0.110
Why?
Hearing Aids
1
2014
68
0.110
Why?
Hypogonadism
1
2013
74
0.110
Why?
DNA
6
1983
1358
0.110
Why?
Hyperplasia
2
2011
166
0.100
Why?
Risk Factors
9
2019
8714
0.100
Why?
Radioimmunotherapy
1
1992
10
0.100
Why?
Risk Assessment
5
2010
3004
0.100
Why?
Prostatic Neoplasms
5
2018
927
0.100
Why?
Neurosecretory Systems
2
2017
32
0.100
Why?
Genetic Variation
1
2017
891
0.100
Why?
Androgens
1
2013
165
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
6
2014
934
0.100
Why?
Histones
1
2016
539
0.100
Why?
Benzamides
1
2012
169
0.100
Why?
Meningeal Neoplasms
4
1986
87
0.100
Why?
Patient Selection
6
2008
656
0.100
Why?
Molecular Sequence Data
6
1999
2793
0.100
Why?
Cognition
2
2009
982
0.100
Why?
Clinical Trials, Phase I as Topic
2
2002
47
0.100
Why?
Cetuximab
3
2008
90
0.100
Why?
Chromosomes, Human, Pair 15
1
2011
53
0.090
Why?
Deltaretrovirus
6
1986
12
0.090
Why?
Transcriptome
1
2016
741
0.090
Why?
Class I Phosphatidylinositol 3-Kinases
3
2015
76
0.090
Why?
MAP Kinase Kinase 1
3
2015
66
0.090
Why?
Antibiotics, Antitubercular
11
1961
35
0.090
Why?
Antibody Formation
2
2022
273
0.090
Why?
Gold
1
2011
105
0.090
Why?
Hearing Loss
1
2014
184
0.090
Why?
Zinc Finger E-box-Binding Homeobox 1
2
2010
23
0.090
Why?
Molecular Structure
2
2005
447
0.090
Why?
Isoenzymes
2
2004
286
0.090
Why?
Pulmonary Surgical Procedures
1
2010
8
0.090
Why?
Radionuclide Imaging
13
1991
121
0.090
Why?
Mucins
1
1990
62
0.090
Why?
Dermatologic Agents
11
1961
57
0.090
Why?
Tuberculosis
19
1970
243
0.090
Why?
Testosterone
1
2013
336
0.090
Why?
Indium
5
1987
10
0.090
Why?
Staphylococcal Infections
7
1981
338
0.090
Why?
Placebos
3
2019
198
0.090
Why?
Catheter Ablation
1
2012
280
0.090
Why?
Lymphoma, B-Cell
1
2010
85
0.090
Why?
Random Allocation
7
2017
338
0.080
Why?
Tocopherols
1
2009
19
0.080
Why?
Expressed Emotion
1
2009
18
0.080
Why?
Isotretinoin
1
2009
22
0.080
Why?
Tumor Virus Infections
3
1984
41
0.080
Why?
Antibodies, Neoplasm
4
2001
29
0.080
Why?
Central Nervous System Diseases
2
1983
62
0.080
Why?
Vasodilator Agents
1
2011
308
0.080
Why?
Blotting, Western
6
2014
1153
0.080
Why?
Kanamycin
6
1970
8
0.080
Why?
MicroRNAs
2
2012
610
0.080
Why?
Mitogen-Activated Protein Kinases
2
2002
277
0.080
Why?
Reproducibility of Results
4
2023
2814
0.080
Why?
Spinal Cord Neoplasms
4
1986
40
0.080
Why?
Fluorenes
1
2009
38
0.080
Why?
Rats
6
2005
5035
0.080
Why?
Vincristine
13
1989
96
0.080
Why?
Receptors, Fibroblast Growth Factor
1
2008
63
0.080
Why?
Cell Survival
5
2013
1026
0.080
Why?
Podophyllotoxin
3
2003
7
0.080
Why?
Aneuploidy
5
2010
86
0.080
Why?
Pulmonary Disease, Chronic Obstructive
2
2007
1115
0.080
Why?
Lymphatic Metastasis
6
2020
275
0.080
Why?
Rats, Nude
4
2003
27
0.080
Why?
Amides
1
2009
89
0.080
Why?
Topotecan
2
2017
14
0.080
Why?
National Institutes of Health (U.S.)
4
1996
106
0.080
Why?
Mice, Inbred BALB C
4
2004
1165
0.080
Why?
Multigene Family
2
2006
196
0.080
Why?
Social Perception
1
2009
97
0.080
Why?
Antisocial Personality Disorder
1
2009
159
0.080
Why?
Patient Acceptance of Health Care
1
2014
682
0.080
Why?
Sample Size
1
2008
119
0.080
Why?
Nanoparticles
1
2011
318
0.080
Why?
Kinetics
8
1991
1560
0.080
Why?
Radiography
8
2002
827
0.080
Why?
Inflammation
1
2018
2503
0.080
Why?
Epithelial Cells
4
2007
965
0.070
Why?
Chromosome Aberrations
6
1993
136
0.070
Why?
Polymorphism, Genetic
1
2011
632
0.070
Why?
Multivariate Analysis
5
2016
1444
0.070
Why?
Exons
2
2019
303
0.070
Why?
Models, Statistical
1
1991
616
0.070
Why?
Incidence
3
2018
2333
0.070
Why?
Bombesin
3
1994
14
0.070
Why?
Immunoglobulins
2
1985
148
0.070
Why?
Fibroblast Growth Factors
1
2008
162
0.070
Why?
Receptors, Growth Factor
2
1997
49
0.070
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2002
301
0.070
Why?
Epitopes
3
1986
438
0.070
Why?
Psychological Tests
1
2007
124
0.070
Why?
Databases, Genetic
2
2018
200
0.070
Why?
Congresses as Topic
3
2020
200
0.070
Why?
Bevacizumab
1
2007
118
0.070
Why?
Cytokines
4
1997
1857
0.070
Why?
Radioisotopes
4
1987
34
0.070
Why?
Mesoderm
1
2007
138
0.070
Why?
Radioimmunoassay
3
1986
163
0.070
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
1987
58
0.070
Why?
Tegafur
1
2005
3
0.070
Why?
Immunologic Factors
3
1996
219
0.070
Why?
Aging
2
2014
1640
0.070
Why?
Platinum Compounds
1
2005
11
0.070
Why?
Adolescent
10
2020
17949
0.070
Why?
Uracil
1
2005
31
0.070
Why?
Teniposide
2
2003
3
0.070
Why?
Receptors, Cell Surface
2
2001
358
0.070
Why?
In Situ Nick-End Labeling
2
2003
119
0.060
Why?
Area Under Curve
2
2005
277
0.060
Why?
Health Knowledge, Attitudes, Practice
1
2014
1193
0.060
Why?
Vascular Endothelial Growth Factor A
1
2008
504
0.060
Why?
Affect
1
2007
244
0.060
Why?
beta 2-Microglobulin
1
1985
45
0.060
Why?
Resting Phase, Cell Cycle
1
2005
15
0.060
Why?
Polymerase Chain Reaction
2
2006
1001
0.060
Why?
PTEN Phosphohydrolase
1
2006
141
0.060
Why?
Anti-Infective Agents
4
2001
225
0.060
Why?
Drug Resistance
5
2006
162
0.060
Why?
Matrix Metalloproteinase Inhibitors
2
2005
13
0.060
Why?
G1 Phase
1
2005
68
0.060
Why?
High-Throughput Nucleotide Sequencing
2
2018
445
0.060
Why?
Binding Sites, Antibody
1
1984
36
0.060
Why?
Radiation, Ionizing
1
2005
73
0.060
Why?
Selenium
2
2004
31
0.060
Why?
Injections, Subcutaneous
3
2002
137
0.060
Why?
Trastuzumab
2
2002
89
0.060
Why?
Regression Analysis
3
2003
961
0.060
Why?
Drug Therapy
5
1983
78
0.060
Why?
Surveys and Questionnaires
4
2014
4670
0.060
Why?
Data Collection
1
2007
636
0.060
Why?
Bortezomib
1
2004
41
0.060
Why?
Animal Welfare
1
2004
14
0.060
Why?
Biological Therapy
1
2004
26
0.060
Why?
Radiotherapy
6
1994
177
0.060
Why?
Retroviridae Infections
4
1985
45
0.060
Why?
JNK Mitogen-Activated Protein Kinases
2
2002
146
0.060
Why?
Lymphoma, Large B-Cell, Diffuse
3
1976
93
0.060
Why?
Karyotyping
6
1996
102
0.060
Why?
Retinoids
1
2004
31
0.060
Why?
Prostaglandin-Endoperoxide Synthases
1
2004
59
0.060
Why?
Planning Techniques
1
2003
13
0.060
Why?
Vaccination
2
2022
1205
0.060
Why?
Decision Making, Organizational
1
2003
25
0.060
Why?
Immunologic Tests
1
2023
16
0.060
Why?
Nucleocapsid
1
2023
17
0.060
Why?
Lymphocytes
1
1985
342
0.060
Why?
Necrosis
1
2004
211
0.060
Why?
Biotechnology
1
2004
46
0.060
Why?
Immunotoxins
2
1995
33
0.060
Why?
Vitamin E
1
2004
111
0.060
Why?
Transfection
1
2006
866
0.060
Why?
Methotrexate
11
1986
228
0.060
Why?
Nervous System Neoplasms
1
1983
2
0.060
Why?
Pilot Projects
3
2012
1374
0.060
Why?
Cyclooxygenase 2
1
2004
165
0.050
Why?
Meninges
4
1982
29
0.050
Why?
Killer Cells, Natural
2
1988
376
0.050
Why?
Radiation Tolerance
1
2004
92
0.050
Why?
Parents
2
2009
1210
0.050
Why?
Pandemics
2
2022
1333
0.050
Why?
Epithelial-Mesenchymal Transition
2
2017
168
0.050
Why?
Skin
7
1987
668
0.050
Why?
Methylmalonic Acid
1
2002
58
0.050
Why?
Proteome
1
2006
344
0.050
Why?
Fruit
1
2003
124
0.050
Why?
Stomach Neoplasms
2
1982
66
0.050
Why?
Vegetables
1
2003
128
0.050
Why?
Enzyme Activation
2
2002
791
0.050
Why?
Farnesyltranstransferase
1
2002
21
0.050
Why?
Metaplasia
2
2018
54
0.050
Why?
Streptozocin
3
1983
16
0.050
Why?
Autoradiography
3
1981
71
0.050
Why?
Injections, Intralesional
1
2002
32
0.050
Why?
Infusion Pumps
1
2002
32
0.050
Why?
Tetrazolium Salts
1
2002
18
0.050
Why?
Oligonucleotide Array Sequence Analysis
4
2007
754
0.050
Why?
Injections, Intraperitoneal
1
2002
104
0.050
Why?
Homocysteine
1
2002
136
0.050
Why?
SEER Program
1
2003
193
0.050
Why?
Peptides
3
2001
862
0.050
Why?
Hypercalcemia
4
1986
21
0.050
Why?
Loss of Heterozygosity
1
2002
41
0.050
Why?
Dietary Supplements
2
2004
460
0.050
Why?
Antigen-Antibody Complex
4
1986
88
0.050
Why?
Multicenter Studies as Topic
1
2003
249
0.050
Why?
Metalloendopeptidases
2
2002
55
0.050
Why?
Mechlorethamine
3
1994
64
0.050
Why?
Mediastinal Neoplasms
1
2002
32
0.050
Why?
Testis
1
2002
134
0.050
Why?
Infusions, Intravenous
3
2004
374
0.050
Why?
Ciprofloxacin
1
2001
23
0.050
Why?
Thiazoles
1
2002
112
0.050
Why?
Leukopenia
5
1995
27
0.050
Why?
Double-Blind Method
2
2019
1665
0.050
Why?
Receptors, Antigen, T-Cell
1
1985
630
0.050
Why?
HIV Infections
1
1996
2469
0.050
Why?
Confidence Intervals
2
2017
310
0.050
Why?
Pedigree
3
2000
474
0.050
Why?
Endpoint Determination
1
2001
69
0.050
Why?
Kinins
1
2001
3
0.050
Why?
Fluorescence
1
2001
153
0.050
Why?
Neoplastic Cells, Circulating
2
1984
59
0.050
Why?
Central Nervous System
1
2023
239
0.050
Why?
Endothelium, Vascular
2
2004
845
0.050
Why?
Leukemia, Plasma Cell
1
1980
5
0.050
Why?
Paraproteinemias
1
1980
4
0.050
Why?
Hypergammaglobulinemia
1
1980
9
0.050
Why?
Cervical Vertebrae
1
2002
104
0.050
Why?
Sensitivity and Specificity
3
2015
1728
0.050
Why?
Plasmacytoma
1
1980
10
0.050
Why?
Lymphoproliferative Disorders
3
1988
46
0.050
Why?
Cell Count
3
1996
304
0.050
Why?
Microtubules
1
2003
238
0.050
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2020
44
0.050
Why?
Microscopy, Fluorescence
1
2002
403
0.050
Why?
Receptors, Interleukin-2
2
1995
65
0.040
Why?
Receptors, Virus
1
2020
76
0.040
Why?
Ploidies
4
2003
17
0.040
Why?
Histocompatibility Antigens Class II
2
2020
353
0.040
Why?
Antioxidants
1
2004
533
0.040
Why?
Algorithms
3
2015
1493
0.040
Why?
Genes, Tumor Suppressor
1
2000
78
0.040
Why?
Neoplasm Invasiveness
2
2015
445
0.040
Why?
Lipoxygenase Inhibitors
1
1999
36
0.040
Why?
Feasibility Studies
2
2000
750
0.040
Why?
Observer Variation
1
2020
299
0.040
Why?
ELAV Proteins
1
1999
17
0.040
Why?
Sepsis
3
1981
519
0.040
Why?
Gene Transfer Techniques
2
1998
149
0.040
Why?
Costs and Cost Analysis
1
2000
200
0.040
Why?
Carcinoembryonic Antigen
1
1979
37
0.040
Why?
Stomach Diseases
1
1979
19
0.040
Why?
Wounds, Nonpenetrating
1
2002
228
0.040
Why?
Colorectal Neoplasms
2
2013
617
0.040
Why?
Streptomycin
8
1954
13
0.040
Why?
Light
1
2001
334
0.040
Why?
Electrons
4
1989
73
0.040
Why?
Case-Control Studies
3
2012
3056
0.040
Why?
Stomach
1
1979
101
0.040
Why?
Spinal Cord Injuries
1
2002
175
0.040
Why?
gamma Catenin
1
2018
17
0.040
Why?
Desmoglein 3
1
2018
17
0.040
Why?
Antibodies
3
1990
374
0.040
Why?
History, 20th Century
2
1996
276
0.040
Why?
Administration, Topical
2
1994
137
0.040
Why?
Carcinoma
4
2001
200
0.040
Why?
Smokers
1
2019
147
0.040
Why?
Postoperative Care
1
2000
222
0.040
Why?
HIV Wasting Syndrome
1
1998
4
0.040
Why?
Protein Kinase C
1
2000
274
0.040
Why?
Skin Diseases
2
1979
124
0.040
Why?
Models, Molecular
2
2018
1391
0.040
Why?
Organoids
1
2019
75
0.040
Why?
Pneumonia
6
1968
576
0.040
Why?
Bronchial Diseases
1
2018
38
0.040
Why?
Hematologic Diseases
3
1995
57
0.040
Why?
RNA, Small Interfering
2
2012
546
0.040
Why?
Teaching
1
2020
226
0.040
Why?
Gastrin-Releasing Peptide
2
1996
6
0.040
Why?
Communicable Diseases
4
1964
131
0.040
Why?
Tissue Distribution
5
1990
324
0.040
Why?
Retinoblastoma Binding Proteins
1
2017
3
0.040
Why?
Genes, p53
1
1998
62
0.040
Why?
DNA Topoisomerases, Type I
1
2017
17
0.040
Why?
Type C Phospholipases
1
1998
66
0.040
Why?
Preoperative Care
1
2000
317
0.040
Why?
North America
1
1998
262
0.040
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1998
171
0.040
Why?
Web Browser
1
2017
11
0.040
Why?
Drug Resistance, Multiple
1
1997
19
0.040
Why?
Demecolcine
1
1976
2
0.040
Why?
Receptors, Notch
1
2017
85
0.040
Why?
B-Lymphocytes
5
1986
770
0.040
Why?
Endocarditis, Subacute Bacterial
3
1964
3
0.040
Why?
Mice, SCID
1
2017
321
0.040
Why?
Longitudinal Studies
1
2003
2437
0.040
Why?
Bronchial Neoplasms
1
1996
14
0.040
Why?
Platinum
1
2016
40
0.040
Why?
Risk
5
2001
830
0.040
Why?
Maximum Tolerated Dose
2
2007
182
0.030
Why?
Tuberculosis, Ocular
5
1954
5
0.030
Why?
T-Lymphocytes, Helper-Inducer
2
1996
129
0.030
Why?
Ubiquitin-Protein Ligases
1
2017
141
0.030
Why?
Antineoplastic Agents, Immunological
1
2018
153
0.030
Why?
Diet
1
2003
1075
0.030
Why?
Carcinogenesis
1
2017
177
0.030
Why?
Mitogens
4
1998
58
0.030
Why?
Endocarditis
3
1964
32
0.030
Why?
RNA-Binding Proteins
1
1999
365
0.030
Why?
Receptors, Cytokine
1
1996
34
0.030
Why?
Comorbidity
2
2016
1476
0.030
Why?
Drug Stability
1
1996
152
0.030
Why?
Colonic Neoplasms
1
2018
221
0.030
Why?
Ovarian Neoplasms
1
2000
407
0.030
Why?
Mice, Inbred NOD
1
2017
562
0.030
Why?
Premedication
1
1995
36
0.030
Why?
Analgesics, Non-Narcotic
1
1997
117
0.030
Why?
Meningitis
4
1974
74
0.030
Why?
Rabbits
10
2005
754
0.030
Why?
Growth Inhibitors
2
2002
45
0.030
Why?
Severity of Illness Index
1
2003
2598
0.030
Why?
Hematopoiesis
1
1976
175
0.030
Why?
Glioblastoma
1
2018
251
0.030
Why?
Cross-Linking Reagents
1
1996
182
0.030
Why?
Pathology, Molecular
1
2015
26
0.030
Why?
GTP-Binding Proteins
1
1996
142
0.030
Why?
Interferon-beta
1
1995
80
0.030
Why?
Colorado
2
2014
4122
0.030
Why?
Drug Tolerance
1
1995
79
0.030
Why?
HLA-A Antigens
2
1985
50
0.030
Why?
Guinea Pigs
3
2005
148
0.030
Why?
Diphtheria Toxin
1
1995
51
0.030
Why?
HLA-C Antigens
2
1985
32
0.030
Why?
Bone Marrow Transplantation
2
1986
241
0.030
Why?
Wnt Signaling Pathway
1
2016
147
0.030
Why?
HLA-B Antigens
2
1985
55
0.030
Why?
Biological Specimen Banks
1
1996
101
0.030
Why?
Whole-Body Irradiation
3
1991
72
0.030
Why?
Photopheresis
1
1994
9
0.030
Why?
Antigens, Viral
4
1984
174
0.030
Why?
Mitomycin
2
1992
27
0.030
Why?
Glioma
1
2018
296
0.030
Why?
Cholecystokinin
1
1994
15
0.030
Why?
Proteins
1
2000
922
0.030
Why?
Molecular Diagnostic Techniques
1
2015
91
0.030
Why?
Cell Cycle Proteins
1
2018
555
0.030
Why?
Methoxsalen
1
1994
4
0.030
Why?
Substance P
1
1994
44
0.030
Why?
Ultraviolet Therapy
1
1994
16
0.030
Why?
gamma-Globulins
2
1965
18
0.030
Why?
Texas
1
2014
187
0.030
Why?
Histiocytoma, Benign Fibrous
1
1994
6
0.030
Why?
Contraindications
1
1994
85
0.030
Why?
Military Medicine
1
1996
93
0.030
Why?
Research
2
1994
398
0.030
Why?
Pyridazines
1
2014
46
0.030
Why?
Fibroblasts
1
1998
838
0.030
Why?
Odds Ratio
1
2016
970
0.030
Why?
Serum Albumin
2
2013
135
0.030
Why?
Consensus
1
2016
533
0.030
Why?
DNA-Binding Proteins
1
2000
1319
0.030
Why?
Micrococcus
3
1958
4
0.030
Why?
Tumor Stem Cell Assay
3
1992
33
0.030
Why?
Staphylococcus
3
1970
69
0.030
Why?
Ileum
2
2005
93
0.030
Why?
Safety
1
1995
298
0.030
Why?
Magnetic Resonance Imaging
2
2023
3086
0.030
Why?
Endoscopy
1
2015
247
0.030
Why?
Urinary Tract Infections
3
1970
136
0.030
Why?
Muscle Denervation
1
1973
9
0.030
Why?
Sex Hormone-Binding Globulin
1
2013
47
0.030
Why?
DNA Fingerprinting
1
2013
27
0.030
Why?
Radiation Dosage
2
1992
141
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
319
0.030
Why?
Maintenance Chemotherapy
1
2013
22
0.030
Why?
In Vitro Techniques
5
2002
1044
0.030
Why?
Auditory Perception
1
2014
101
0.030
Why?
Imidazoles
1
2014
215
0.030
Why?
Solid Phase Microextraction
1
2012
6
0.030
Why?
Treatment Failure
1
1994
333
0.030
Why?
NAD(P)H Dehydrogenase (Quinone)
1
1992
31
0.030
Why?
DNA Primers
2
2009
513
0.030
Why?
Neuromuscular Junction
1
1973
53
0.030
Why?
Chromosome Banding
4
1996
21
0.030
Why?
Cooperative Behavior
1
2015
390
0.030
Why?
Pyrimidinones
1
2013
86
0.030
Why?
Breath Tests
1
2012
85
0.030
Why?
Luteinizing Hormone
1
2013
169
0.030
Why?
Gas Chromatography-Mass Spectrometry
1
2012
127
0.030
Why?
Hearing
1
2014
132
0.030
Why?
Recombinant Fusion Proteins
1
1995
616
0.030
Why?
International Cooperation
2
2003
175
0.030
Why?
Bone Marrow Examination
1
1992
7
0.030
Why?
Liver
5
1987
1693
0.030
Why?
Adrenocorticotropic Hormone
4
1954
148
0.030
Why?
Ionomycin
1
1992
24
0.030
Why?
Species Specificity
2
2005
555
0.030
Why?
Ricin
1
1991
8
0.030
Why?
Follicle Stimulating Hormone
1
2013
214
0.030
Why?
Probability
3
2009
297
0.030
Why?
Benzimidazoles
1
2013
137
0.030
Why?
Pyridones
1
2013
123
0.030
Why?
Immunization, Passive
2
2001
79
0.030
Why?
Equipment Design
1
2014
516
0.030
Why?
Nanostructures
1
2013
98
0.030
Why?
Chromosome Deletion
2
1982
95
0.030
Why?
Ambulatory Care
1
1995
480
0.020
Why?
Properdin
2
1962
8
0.020
Why?
Radiometry
1
1992
43
0.020
Why?
Logistic Models
1
2016
1865
0.020
Why?
Gene Frequency
1
2013
507
0.020
Why?
Residence Characteristics
1
2014
278
0.020
Why?
Tuberculosis, Pulmonary
4
1959
112
0.020
Why?
Immunosorbent Techniques
1
1991
17
0.020
Why?
Drug Hypersensitivity
2
1970
86
0.020
Why?
Laboratories
2
1963
95
0.020
Why?
Waldenstrom Macroglobulinemia
2
1982
11
0.020
Why?
Cross-Sectional Studies
2
2015
4449
0.020
Why?
Vimentin
1
2011
58
0.020
Why?
Acquired Immunodeficiency Syndrome
2
1990
221
0.020
Why?
Japan
2
2009
89
0.020
Why?
Lomustine
7
1986
14
0.020
Why?
Iceland
1
2011
6
0.020
Why?
Drug Evaluation, Preclinical
1
1992
165
0.020
Why?
Perception
1
2014
316
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
12
0.020
Why?
Evidence-Based Medicine
1
2015
686
0.020
Why?
Enzyme-Linked Immunosorbent Assay
2
2009
794
0.020
Why?
Spain
1
2011
36
0.020
Why?
Mutation, Missense
1
2013
296
0.020
Why?
Antibodies, Anti-Idiotypic
1
1991
54
0.020
Why?
Netherlands
1
2011
65
0.020
Why?
Adsorption
1
1991
127
0.020
Why?
Zinc Finger E-box Binding Homeobox 2
1
2010
5
0.020
Why?
Databases, Factual
1
1996
1149
0.020
Why?
Motor Neurons
1
1973
213
0.020
Why?
Thyroid Neoplasms
1
1994
261
0.020
Why?
Photochemotherapy
2
1980
29
0.020
Why?
Diagnosis, Differential
2
2002
1358
0.020
Why?
Tissue Array Analysis
1
2010
49
0.020
Why?
Megakaryocytes
3
1980
30
0.020
Why?
Serine Endopeptidases
1
2010
102
0.020
Why?
Sequence Homology, Nucleic Acid
1
1990
150
0.020
Why?
Radiotherapy, High-Energy
2
1980
12
0.020
Why?
Base Sequence
2
2009
2120
0.020
Why?
Antibody-Dependent Cell Cytotoxicity
2
1988
19
0.020
Why?
Clone Cells
3
1985
247
0.020
Why?
Nervous System Diseases
3
1985
253
0.020
Why?
Carrier Proteins
1
1994
703
0.020
Why?
Nicotinic Acids
3
1954
6
0.020
Why?
Hemagglutination Tests
2
1964
7
0.020
Why?
Mitosis
3
1981
164
0.020
Why?
Niacin
3
1954
19
0.020
Why?
Bacterial Infections
2
2001
222
0.020
Why?
Down-Regulation
1
1992
605
0.020
Why?
Calcitriol
2
1986
53
0.020
Why?
Proteomics
2
2007
854
0.020
Why?
Deafness
1
1970
78
0.020
Why?
Referral and Consultation
1
2014
647
0.020
Why?
Diethylstilbestrol
2
1986
8
0.020
Why?
Isoniazid
3
1954
52
0.020
Why?
Personality Inventory
1
2009
135
0.020
Why?
Thoracic Surgery
1
2010
107
0.020
Why?
Insulin-Like Growth Factor I
1
1991
281
0.020
Why?
Infusions, Parenteral
2
1986
38
0.020
Why?
Immunoprecipitation
1
2009
154
0.020
Why?
Pulmonary Fibrosis
2
1986
331
0.020
Why?
Ovary
1
1990
190
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2011
389
0.020
Why?
Tomography, X-Ray Computed
3
2002
2408
0.020
Why?
Histocytochemistry
3
1983
78
0.020
Why?
Herpes Simplex
2
1987
88
0.020
Why?
Tuberculosis, Meningeal
4
1964
6
0.020
Why?
Immunophenotyping
2
2001
273
0.020
Why?
Statistics, Nonparametric
1
2009
390
0.020
Why?
Tetracycline
2
1958
11
0.020
Why?
Fluorescent Antibody Technique
2
1987
399
0.020
Why?
Bone Marrow Cells
3
1980
272
0.020
Why?
New South Wales
1
2007
10
0.020
Why?
In Situ Hybridization
1
2008
298
0.020
Why?
Rosette Formation
2
1987
16
0.020
Why?
Queensland
1
2007
40
0.020
Why?
Ampicillin
2
1965
13
0.020
Why?
Protein Synthesis Inhibitors
2
1958
44
0.020
Why?
Eye
3
1954
101
0.020
Why?
Actuarial Analysis
1
1987
21
0.020
Why?
Repressor Proteins
1
2010
369
0.020
Why?
Body Fluids
2
1964
58
0.020
Why?
Remission, Spontaneous
4
1980
37
0.020
Why?
Receptors, Progesterone
1
1989
319
0.020
Why?
Hydrocortisone
2
1981
272
0.020
Why?
Pneumonia, Pneumococcal
2
1960
37
0.020
Why?
Procarbazine
5
1986
8
0.020
Why?
Dyspnea
2
1986
223
0.020
Why?
Genome, Human
1
2009
374
0.020
Why?
Principal Component Analysis
1
2007
181
0.020
Why?
California
1
2008
369
0.020
Why?
Reference Values
1
2008
745
0.020
Why?
Calcitonin
1
1986
23
0.020
Why?
Nucleotidases
2
1985
7
0.020
Why?
Colony-Forming Units Assay
1
1986
92
0.020
Why?
Child
4
2009
18550
0.020
Why?
Genome
1
2009
266
0.020
Why?
Bacillus
2
1957
14
0.020
Why?
Child, Preschool
3
2007
9174
0.020
Why?
Phosphates
2
1958
160
0.020
Why?
Diagnostic Imaging
1
2009
296
0.020
Why?
DNA Repair
1
2008
192
0.020
Why?
Sulfadiazine
1
1966
4
0.020
Why?
Nocardia Infections
1
1966
7
0.020
Why?
Gram-Positive Bacteria
2
1957
46
0.020
Why?
Immunoglobulin Idiotypes
1
1986
19
0.020
Why?
Insecta
2
1957
63
0.020
Why?
Radioisotope Dilution Technique
1
1986
13
0.020
Why?
Antigen-Antibody Reactions
1
1966
49
0.020
Why?
Farmer's Lung
1
1965
3
0.020
Why?
Dose-Response Relationship, Immunologic
1
1986
82
0.020
Why?
Erythromycin
2
1958
24
0.020
Why?
Mice, Inbred A
1
2005
45
0.020
Why?
Databases, Nucleic Acid
1
2005
32
0.020
Why?
Deoxyribonucleosides
1
1985
2
0.020
Why?
Urea
1
1966
69
0.020
Why?
Dose-Response Relationship, Radiation
1
1986
129
0.020
Why?
Indicators and Reagents
1
1986
100
0.020
Why?
Peritonitis
1
1966
76
0.020
Why?
DNA Damage
1
2008
356
0.020
Why?
Cell Movement
2
1981
868
0.020
Why?
Freezing
1
1986
85
0.020
Why?
Mathematics
1
1986
101
0.020
Why?
Mycoses
1
1966
67
0.020
Why?
Blood
1
1985
97
0.020
Why?
HLA-B35 Antigen
1
1985
3
0.020
Why?
HLA-B8 Antigen
1
1985
14
0.020
Why?
Enzymes
1
2005
61
0.020
Why?
Analysis of Variance
1
2008
1226
0.020
Why?
Bleomycin
2
1978
232
0.020
Why?
Phenylalanine
1
2005
58
0.020
Why?
Carcinogens
1
2005
105
0.020
Why?
Nucleic Acid Hybridization
1
1985
187
0.020
Why?
Antigens, Differentiation, T-Lymphocyte
1
1985
84
0.020
Why?
Haemophilus
1
1965
4
0.020
Why?
Viral Proteins
3
1981
283
0.020
Why?
Lymphokines
1
1985
115
0.020
Why?
Mitomycins
1
1984
3
0.020
Why?
Myeloma Proteins
1
1984
7
0.020
Why?
Genes, MHC Class II
1
1985
69
0.020
Why?
Endocytosis
1
1986
152
0.020
Why?
Melphalan
1
1984
29
0.020
Why?
Histocompatibility Testing
1
1985
115
0.020
Why?
Exanthema
1
2005
77
0.020
Why?
Carmustine
1
1984
47
0.020
Why?
Monocytes
2
1985
504
0.020
Why?
Tyrosine
1
2005
218
0.020
Why?
Endocarditis, Bacterial
1
1965
36
0.020
Why?
Syndrome
3
1984
339
0.020
Why?
Cross Reactions
1
1984
116
0.010
Why?
DNA Replication
1
2005
204
0.010
Why?
Psychology, Child
1
2004
37
0.010
Why?
Acute Disease
2
1984
917
0.010
Why?
Genome-Wide Association Study
1
2011
1301
0.010
Why?
Hemagglutination
1
1964
7
0.010
Why?
Bronchopneumonia
1
1964
5
0.010
Why?
Nephritis, Interstitial
1
1984
7
0.010
Why?
DNA, Recombinant
1
1984
42
0.010
Why?
Acetaminophen
1
1987
237
0.010
Why?
Expectorants
1
1964
24
0.010
Why?
Nephrosis, Lipoid
1
1984
10
0.010
Why?
Hypersensitivity, Delayed
1
1983
52
0.010
Why?
Prednisone
1
1984
232
0.010
Why?
Gene Expression Regulation, Enzymologic
1
2005
274
0.010
Why?
Fatigue
1
2005
295
0.010
Why?
Densitometry
2
1980
29
0.010
Why?
Chromosomes
2
1982
85
0.010
Why?
Chromosomes, Human, Pair 7
1
2003
15
0.010
Why?
Cell Transformation, Viral
2
1984
24
0.010
Why?
Paraneoplastic Syndromes
1
1983
13
0.010
Why?
Toxicology
1
1964
36
0.010
Why?
Muscles
3
1982
328
0.010
Why?
Virus Diseases
1
1966
200
0.010
Why?
3',5'-Cyclic-GMP Phosphodiesterases
1
2003
17
0.010
Why?
Vital Capacity
1
2004
279
0.010
Why?
Growth Hormone
2
1954
99
0.010
Why?
Mycobacterium tuberculosis
2
1957
268
0.010
Why?
Vitamins
1
2004
151
0.010
Why?
Biopsy, Needle
2
1982
183
0.010
Why?
Cloxacillin
1
1963
1
0.010
Why?
Tuberculosis, Miliary
3
1964
5
0.010
Why?
Furunculosis
1
1962
1
0.010
Why?
Pneumococcal Infections
2
1956
91
0.010
Why?
Sex Ratio
1
1983
14
0.010
Why?
Razoxane
1
1982
1
0.010
Why?
Drainage
1
1964
151
0.010
Why?
Receptors, Bradykinin
1
2002
4
0.010
Why?
Transfer Factor
1
1983
24
0.010
Why?
Thymosin
2
1980
5
0.010
Why?
Leukapheresis
1
1983
25
0.010
Why?
Poly(ADP-ribose) Polymerases
1
2003
88
0.010
Why?
Lymphocyte Activation
3
1983
1056
0.010
Why?
Antilymphocyte Serum
1
1983
66
0.010
Why?
Cell Membrane
2
2002
682
0.010
Why?
Allergy and Immunology
1
1964
56
0.010
Why?
T-Lymphocytes, Cytotoxic
1
1983
156
0.010
Why?
Pentosyltransferases
1
1982
3
0.010
Why?
Streptococcal Infections
1
1965
132
0.010
Why?
Nucleoside Deaminases
1
1982
2
0.010
Why?
Purine-Nucleoside Phosphorylase
1
1982
5
0.010
Why?
Bacteriophages
2
1961
76
0.010
Why?
Autopsy
1
1983
86
0.010
Why?
Cysteine
1
1964
173
0.010
Why?
Cells, Cultured
7
1985
3916
0.010
Why?
Keratins
1
2003
176
0.010
Why?
Adenosine Deaminase
1
1982
26
0.010
Why?
Immunity, Cellular
2
1984
263
0.010
Why?
Forced Expiratory Volume
1
2004
522
0.010
Why?
Gastrointestinal Tract
1
2004
169
0.010
Why?
Umbilical Cord
1
2002
80
0.010
Why?
Aggression
1
2004
186
0.010
Why?
Receptors, Fc
1
1982
45
0.010
Why?
Agglutinins
1
1962
2
0.010
Why?
Clinical Enzyme Tests
1
1982
11
0.010
Why?
Abdominal Neoplasms
1
1982
26
0.010
Why?
Leukemia, Erythroblastic, Acute
1
1982
8
0.010
Why?
Phosphopyruvate Hydratase
1
1982
30
0.010
Why?
Manipulation, Spinal
1
2002
8
0.010
Why?
Sulfonamides
2
1955
447
0.010
Why?
Caspases
1
2003
245
0.010
Why?
Complement System Proteins
2
1962
288
0.010
Why?
Rectal Diseases
1
1981
17
0.010
Why?
Herpesvirus 4, Human
2
1980
123
0.010
Why?
Bone Resorption
1
1982
74
0.010
Why?
Carcinoma, Hepatocellular
1
1983
224
0.010
Why?
False Positive Reactions
1
2002
111
0.010
Why?
Receptors, Immunologic
1
1983
201
0.010
Why?
Phenotype
4
1984
2858
0.010
Why?
Promoter Regions, Genetic
1
2006
1129
0.010
Why?
Immune System
1
1983
173
0.010
Why?
Glasgow Coma Scale
1
2002
144
0.010
Why?
CD52 Antigen
1
2001
3
0.010
Why?
Oculomotor Muscles
2
1951
40
0.010
Why?
Alemtuzumab
1
2001
12
0.010
Why?
Zymosan
1
1961
63
0.010
Why?
APUD Cells
1
1980
1
0.010
Why?
Furocoumarins
1
1980
8
0.010
Why?
Single-Blind Method
1
2001
256
0.010
Why?
Neoplasms, Hormone-Dependent
1
2000
38
0.010
Why?
Polysaccharides
1
1961
79
0.010
Why?
Cell Line, Transformed
1
2000
133
0.010
Why?
Leukocytes
2
1984
284
0.010
Why?
Amyloidosis
1
1980
36
0.010
Why?
Intestinal Neoplasms
1
1980
24
0.010
Why?
Hospitals, Chronic Disease
2
1958
2
0.010
Why?
Immunoglobulin Heavy Chains
1
1980
72
0.010
Why?
Piperazines
1
1982
313
0.010
Why?
Neoplasm, Residual
1
2001
105
0.010
Why?
Cytological Techniques
1
1980
23
0.010
Why?
Biological Assay
1
2001
114
0.010
Why?
Chromosomes, Human
1
1980
40
0.010
Why?
Soft Tissue Neoplasms
1
1981
90
0.010
Why?
Antiviral Agents
1
1966
648
0.010
Why?
Bacteremia
1
1962
159
0.010
Why?
Hypersensitivity
1
1964
272
0.010
Why?
Quality Assurance, Health Care
1
2002
319
0.010
Why?
Brain
3
1985
2382
0.010
Why?
Health Resources
1
2001
122
0.010
Why?
Influenza, Human
1
1985
549
0.010
Why?
Disease Management
1
1964
562
0.010
Why?
Range of Motion, Articular
1
2002
353
0.010
Why?
Thymus Hormones
1
1979
1
0.010
Why?
Joint Instability
1
2002
166
0.010
Why?
Carcinogens, Environmental
1
1979
6
0.010
Why?
Stomach Ulcer
1
1979
9
0.010
Why?
Gastroscopy
1
1979
18
0.010
Why?
Duodenal Ulcer
1
1979
10
0.010
Why?
Osteoporosis
1
1982
227
0.010
Why?
Spinal Cord
1
1982
351
0.010
Why?
History, 19th Century
1
1979
57
0.010
Why?
Glycoproteins
1
2001
308
0.010
Why?
Neuroblastoma
1
1980
130
0.010
Why?
Cost-Benefit Analysis
1
2002
545
0.010
Why?
Blood Platelets
2
1984
350
0.010
Why?
Hybridomas
2
1994
230
0.010
Why?
Spinal Cord Compression
1
1978
17
0.010
Why?
Demeclocycline
1
1978
3
0.010
Why?
Protein Biosynthesis
1
2000
388
0.010
Why?
Antigens, CD
1
2001
442
0.010
Why?
Polymorphism, Single-Stranded Conformational
1
1998
29
0.010
Why?
Phospholipase C beta
1
1998
26
0.010
Why?
Gastritis
1
1979
84
0.010
Why?
Chloramphenicol
1
1958
6
0.010
Why?
Practice Patterns, Physicians'
1
2006
1177
0.010
Why?
Levamisole
1
1998
20
0.010
Why?
Vasopressins
1
1978
57
0.010
Why?
Estradiol
1
1981
453
0.010
Why?
Radiation Injuries
1
1979
128
0.010
Why?
Antibody Specificity
3
1983
180
0.010
Why?
T-Lymphocytes, Regulatory
1
1980
340
0.010
Why?
Cell Separation
3
1986
293
0.010
Why?
Hormones, Ectopic
1
1977
2
0.010
Why?
Occupational Diseases
1
1979
129
0.010
Why?
Pregnancy
1
1989
5555
0.010
Why?
Fluorouracil
1
1998
151
0.010
Why?
GPI-Linked Proteins
1
1997
54
0.010
Why?
Thoracotomy
1
1997
67
0.010
Why?
Amantadine
2
1968
7
0.010
Why?
Vinca Alkaloids
1
1976
1
0.010
Why?
Capsules
1
1957
36
0.010
Why?
Genetic Markers
1
1998
337
0.010
Why?
Cephalosporins
2
1968
26
0.010
Why?
Immunoglobulin G
2
1994
782
0.010
Why?
Staining and Labeling
1
1977
139
0.010
Why?
Penicillin V
1
1956
3
0.010
Why?
Gentamicins
2
1968
43
0.010
Why?
Cycloserine
1
1956
3
0.010
Why?
Colchicine
1
1976
24
0.010
Why?
Novobiocin
1
1956
5
0.010
Why?
Maryland
1
1996
37
0.010
Why?
Gallium Radioisotopes
1
1975
19
0.010
Why?
Computer Communication Networks
1
1996
33
0.010
Why?
Arthritis
1
1957
110
0.010
Why?
Sulfisoxazole
1
1955
1
0.010
Why?
Laparoscopy
1
1980
400
0.010
Why?
Herpes Zoster
1
1980
333
0.010
Why?
Glycopeptides
1
1996
43
0.010
Why?
Cerebrospinal Fluid
1
1976
88
0.010
Why?
Cyclic AMP
1
1996
227
0.010
Why?
Streptococcus pneumoniae
1
1956
133
0.010
Why?
Bronchoalveolar Lavage Fluid
1
1997
609
0.010
Why?
Folate Receptors, GPI-Anchored
1
1994
5
0.010
Why?
Portal System
1
1953
13
0.010
Why?
Phlebitis
1
1953
10
0.010
Why?
Respiratory Function Tests
2
1986
541
0.010
Why?
Leucomycins
1
1953
1
0.010
Why?
Dogs
2
1987
344
0.010
Why?
Veins
1
1953
57
0.010
Why?
Thyroid Gland
1
1994
83
0.010
Why?
Isomerism
1
1953
42
0.010
Why?
Heart Neoplasms
1
1994
50
0.010
Why?
Gallamine Triethiodide
1
1973
1
0.010
Why?
Edrophonium
1
1973
2
0.010
Why?
Organ Specificity
1
1994
273
0.010
Why?
Disease
1
1953
83
0.010
Why?
Pulmonary Alveoli
1
1996
376
0.010
Why?
Human Growth Hormone
1
1953
38
0.010
Why?
Sciatic Nerve
1
1973
56
0.010
Why?
Cats
1
1973
205
0.010
Why?
Appendicitis
1
1953
110
0.010
Why?
Chromosomes, Human, 1-3
2
1982
2
0.010
Why?
RNA, Neoplasm
1
1992
80
0.010
Why?
Meningitis, Pneumococcal
1
1952
7
0.010
Why?
Cytotoxicity, Immunologic
2
1983
196
0.010
Why?
Killer Cells, Lymphokine-Activated
1
1992
9
0.010
Why?
Electric Stimulation
1
1973
263
0.010
Why?
Recurrence
3
1980
949
0.010
Why?
Models, Biological
1
1979
1647
0.010
Why?
Hormones
1
1952
132
0.010
Why?
Erythrocytes
1
1976
590
0.010
Why?
Evaluation Studies as Topic
2
1982
170
0.010
Why?
Insulin
1
1981
2083
0.010
Why?
Perfusion
1
1992
152
0.010
Why?
Klebsiella
1
1970
2
0.010
Why?
Vestibulocochlear Nerve
1
1970
6
0.010
Why?
Synaptic Transmission
1
1973
232
0.010
Why?
Blood Cell Count
2
1981
52
0.010
Why?
Organ of Corti
1
1970
14
0.010
Why?
Chlortetracycline
1
1950
4
0.010
Why?
Kidney
2
1984
1208
0.010
Why?
Drug Resistance, Microbial
1
1970
66
0.010
Why?
Culture Media
2
1981
156
0.010
Why?
Injections
1
1991
163
0.010
Why?
Enterobacteriaceae Infections
1
1970
33
0.010
Why?
Microscopy, Electron
2
1982
406
0.010
Why?
Paralysis
1
1970
67
0.010
Why?
Muscle Contraction
1
1973
398
0.010
Why?
Action Potentials
1
1973
408
0.010
Why?
Promegestone
1
1989
33
0.010
Why?
Formaldehyde
1
1989
47
0.010
Why?
Chickenpox
1
1950
94
0.010
Why?
Vomiting
2
1981
125
0.010
Why?
Neuromuscular Diseases
1
1970
90
0.010
Why?
DNA Nucleotidyltransferases
1
1968
11
0.000
Why?
Thrombocythemia, Essential
1
1988
6
0.000
Why?
Polymyxins
1
1968
9
0.000
Why?
Immunoglobulin Isotypes
1
1987
32
0.000
Why?
Hepatic Insufficiency
1
1947
4
0.000
Why?
Whole-Body Counting
1
1987
4
0.000
Why?
Infant
1
1980
8002
0.000
Why?
Lysosomes
1
1968
126
0.000
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1988
93
0.000
Why?
Propidium
1
1986
4
0.000
Why?
Medroxyprogesterone
1
1986
10
0.000
Why?
Kidney Diseases
1
1970
355
0.000
Why?
Medroxyprogesterone Acetate
1
1986
29
0.000
Why?
Coloring Agents
1
1986
71
0.000
Why?
Orchiectomy
1
1986
57
0.000
Why?
Cephaloridine
1
1966
1
0.000
Why?
Immunoglobulin M
1
1987
251
0.000
Why?
Immunodiffusion
1
1965
9
0.000
Why?
Sulfanilamides
2
1955
2
0.000
Why?
Spleen
1
1987
491
0.000
Why?
Polymers
1
1989
464
0.000
Why?
Immunization
1
1987
402
0.000
Why?
Tuberculosis, Renal
1
1964
1
0.000
Why?
Canada
1
1965
337
0.000
Why?
Death, Sudden
1
1964
33
0.000
Why?
Purines
1
1985
159
0.000
Why?
Memory Disorders
1
1985
155
0.000
Why?
Pathology
1
1964
21
0.000
Why?
Polyethylene Glycols
1
1989
576
0.000
Why?
Molecular Weight
1
1984
335
0.000
Why?
Cell Differentiation
2
1985
1706
0.000
Why?
Blood Cells
1
1984
39
0.000
Why?
Urticaria
1
1984
51
0.000
Why?
Leucovorin
1
1983
42
0.000
Why?
Respiratory Tract Infections
1
1968
323
0.000
Why?
West Indies
1
1983
5
0.000
Why?
Alabama
1
1983
28
0.000
Why?
Leukemia, Hairy Cell
1
1983
6
0.000
Why?
Georgia
1
1983
59
0.000
Why?
Florida
1
1983
73
0.000
Why?
Aspartate Aminotransferases
1
1983
87
0.000
Why?
Skin Tests
1
1983
137
0.000
Why?
Warfarin
1
1984
136
0.000
Why?
Osteosclerosis
1
1982
2
0.000
Why?
Anemia, Sideroblastic
1
1982
3
0.000
Why?
Pulmonary Embolism
1
1964
182
0.000
Why?
Leukocyte Count
1
1982
295
0.000
Why?
Creatinine
1
1983
431
0.000
Why?
Agranulocytosis
1
1981
31
0.000
Why?
Adrenal Glands
1
1982
72
0.000
Why?
Technetium Tc 99m Pyrophosphate
1
1981
1
0.000
Why?
Peripheral Nerves
1
1982
65
0.000
Why?
Viral Core Proteins
1
1981
18
0.000
Why?
Diphosphates
1
1981
16
0.000
Why?
Electrophysiology
1
1982
202
0.000
Why?
Mental Disorders
1
1949
908
0.000
Why?
Technetium
1
1981
22
0.000
Why?
Transferrin
1
1981
40
0.000
Why?
Nausea
1
1981
103
0.000
Why?
Substance-Related Disorders
1
1949
953
0.000
Why?
Abscess
1
1981
73
0.000
Why?
Immune Sera
1
1981
80
0.000
Why?
Fluorometry
1
1980
19
0.000
Why?
Photomicrography
1
1980
7
0.000
Why?
Microscopy, Phase-Contrast
1
1980
18
0.000
Why?
DNA-Directed DNA Polymerase
1
1980
44
0.000
Why?
Dermatitis, Exfoliative
1
1980
4
0.000
Why?
Haplorhini
1
1980
59
0.000
Why?
Purpura
1
1980
12
0.000
Why?
Castration
1
1980
14
0.000
Why?
Macrophage Migration-Inhibitory Factors
1
1980
14
0.000
Why?
Alopecia
1
1979
28
0.000
Why?
Receptors, Complement
1
1980
112
0.000
Why?
Receptors, Antigen, B-Cell
1
1980
102
0.000
Why?
Cocarcinogenesis
1
1979
14
0.000
Why?
Chemical Industry
1
1979
9
0.000
Why?
Methods
1
1978
59
0.000
Why?
Fiber Optic Technology
1
1978
17
0.000
Why?
Hemoglobins
1
1981
313
0.000
Why?
Pesticides
1
1979
49
0.000
Why?
Solvents
1
1979
109
0.000
Why?
Mucous Membrane
1
1978
108
0.000
Why?
Granulocytes
1
1976
78
0.000
Why?
Herpesvirus 3, Human
1
1980
381
0.000
Why?
Air Pollutants
1
1979
285
0.000
Why?
Postoperative Complications
1
1983
2167
0.000
Why?
Hospitals, University
1
1946
172
0.000
Why?
Biological Transport
1
1946
373
0.000
Why?
Minnesota
1
1964
134
0.000
Why?
Students
1
1946
503
0.000
Why?
Bunn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)